In Vitro Activity of Cefaclor Against Aerobic and Anaerobic Bacteria
AUTOR(ES)
Bach, Vinh T.
RESUMO
Cefaclor (CCL), a new cephalosporin, was tested in vitro against 602 (271 anaerobic and 331 aerobic) clinical isolates in comparison with cephalothin, cefazolin, cephradine, and cefamandole. Sixteen micrograms of CCL per ml inhibited 68% of all aerobes tested and 80% of the 211 enteropathogenic organisms (Escherichia coli, Salmonella, and Shigella) isolated from cases of infantile diarrhoea. CCL inhibited 88% of gram-positive anaerobic cocci and 72% of Bacteroides other than B. fragilis at a concentration of 16 μg/ml. B. fragilis and Clostridia were resistant to CCL. Increased inoculum of E. coli from 105 to 109 increased the minimal inhibitory concentration of CCL and cefamandole by fourfold against 7 of the 64 strains tested. All seven were beta-lactamase negative. No antimicrobial synergism was noted between CCL and penicillin. The in vitro efficacy of CCL, an oral cephalosporin, against enteropathogenic E. coli, if proven safe, may be tested in vivo against such infections.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352216Documentos Relacionados
- In Vitro Activity of Mezlocillin and Its Related Compounds Against Aerobic and Anaerobic Bacteria
- Activity of Cefamandole and Other Cephalosporins Against Aerobic and Anaerobic Bacteria
- In vitro activity of MDL 62,879 (GE2270 A) against aerobic gram-positive and anaerobic bacteria.
- In vitro activity of cefbuperazone against anaerobic bacteria.
- In vitro activity of mecillinam against anaerobic bacteria.
